FRANKFURT (Reuters) - German chemicals group BASF (BASFn.DE) has agreed to sell parts of its pharmaceutical ingredients business to Swiss drug contract manufacturer Siegfried Holding (SFZN.S) for 270 million euros ($306 million), including assumed debt.
"Siegfried will reach the critical size to play a leading role in the supplier market as a recognized partner for the pharmaceutical industry," said Siegfried Chief Executive Rudolf Hanko.
14:56 Read what Steven Mnuchin will say at his Treasury confirmation hearing18
00:06 Business manager for Alanis Morissette, other celebrities admits to stealing more than $6.5M from his clients16
19:44 Revised MLS stadium plan cuts St. Louis' share by $20M12
02:14 Green Bay Packers expected to cut Sam Shields21